Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
UMC119-06-05
BIOLOGICAL
3 trials
Sponsors
Meridigen Biotech Co., Ltd.
, Meribank Biotech Co., Ltd.
Conditions
Chronic Obstructive Pulmonary Disease
Frailty Syndrome
Osteoarthritis, Knee
Phase 1
Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).
NCT04893174
Meridigen Biotech Co., Ltd.
Osteoarthritis, Knee
Start: 2022-09-15
End: 2025-06-30
Target: 6
Updated: 2023-12-04
Mesenchymal Stem Cells for The Treatment of Frailty Syndrome
NCT04914403
Meridigen Biotech Co., Ltd.
Frailty Syndrome
Start: 2021-09-01
End: 2025-07-31
Target: 6
Updated: 2023-12-04
Phase 2
Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
Recruiting
NCT06491043
Meribank Biotech Co., Ltd.
Chronic Obstructive Pulmonary Disease
Start: 2024-06-11
End: 2027-12-30
Target: 90
Updated: 2024-07-08